- AU$42.73m
- AU$44.16m
- AU$34.87m
Australia Stock Exchange release from NOVA EYE MED : Application for quotation of securities - EYE
Australia Stock Exchange release from NOVA EYE MED : Proposed issue of securities - EYE
Australia Stock Exchange release from NOVA EYE MED : PRE_NR Ends: 10:03:40
Australia Stock Exchange release from NOVA EYE MED : Aquisition of Glaucoma Patents
Australia Stock Exchange release from NOVA EYE MED : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from NOVA EYE MED : FY21 Investor presentation
Australia Stock Exchange release from NOVA EYE MED : PRE_NR Ends: 08:23:41
Australia Stock Exchange release from NOVA EYE MED : Full Year Results FY21
Australia Stock Exchange release from NOVA EYE MED : PRE_NR Ends: 08:23:26
Australia Stock Exchange release from NOVA EYE MED : PRE_NR Ends: 08:23:11
Australia Stock Exchange release from NOVA EYE MED : FY21 Appendix 4E and Annual Report
Australia Stock Exchange release from NOVA EYE MED : Proposed issue of securities - EYE
Australia Stock Exchange release from NOVA EYE MED : Notice of Upcoming Investor Call - Full Year (FY21) Results
Brief: Nova Eye Medical Announces FY21 Trading Update
Australia Stock Exchange release from NOVA EYE MED : Shareholder letter holders of less than marketable Parcel
Australia Stock Exchange release from NOVA EYE MED : Share Sale Facility for Less Than Marketable Parcels
Australia's Nova Eye Medical at near 2-month high on IDE application for 2RT
Brief: Nova Eye Medical Announces Filing Of Investigational Device Exemption Application With US FDA
Australia Stock Exchange release from NOVA EYE MED : IDE Application for 2RT filed with the FDA